Viewing Study NCT04782193


Ignite Creation Date: 2025-12-25 @ 1:26 AM
Ignite Modification Date: 2026-01-22 @ 8:54 PM
Study NCT ID: NCT04782193
Status: UNKNOWN
Last Update Posted: 2023-04-18
First Post: 2021-02-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: a Clinical Research of CD19 and CD22 Targeted Prime CAR-T Cell in Relapsed/Refractory B Cell Lymphoma
Sponsor: Chongqing Precision Biotech Co., Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module